Arbiter Settles Santaris-Exiqon LNA Dispute; Each Firm Claims Victory
October 13, 2011
Arbiter Settles Santaris-Exiqon LNA Dispute; Each Firm Claims Victory
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Products: Exiqon's qPCR Assay-Design Tool
June 14, 2012 / Gene Silencing News - With Positive Phase II Data on HCV Drug, Santaris Aims for Another Clinical Trial by the Summer
April 26, 2012 / Gene Silencing News - In Countersuit, Santaris Aims to Invalidate Isis Gapmer Patents
December 15, 2011 / Gene Silencing News - Products & Services
October 13, 2011 / Gene Silencing News - Santaris Releases Phase II Data Showing Its HCV Drug Is Well Tolerated, Effective
October 6, 2011 / Gene Silencing News